NM_005751.5:c.2581T>C
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_005751.5(AKAP9):c.2581T>C(p.Tyr861His) variant causes a missense change. The variant allele was found at a frequency of 0.000598 in 1,610,938 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y861S) has been classified as Uncertain significance.
Frequency
Consequence
NM_005751.5 missense
Scores
Clinical Significance
Conservation
Publications
- male infertility with azoospermia or oligozoospermia due to single gene mutationInheritance: AR Classification: MODERATE Submitted by: King Faisal Specialist Hospital and Research Center
- long QT syndrome 11Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- long QT syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000638 AC: 97AN: 152086Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000724 AC: 178AN: 245788 AF XY: 0.000728 show subpopulations
GnomAD4 exome AF: 0.000595 AC: 868AN: 1458734Hom.: 0 Cov.: 35 AF XY: 0.000608 AC XY: 441AN XY: 725444 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000631 AC: 96AN: 152204Hom.: 0 Cov.: 33 AF XY: 0.000887 AC XY: 66AN XY: 74418 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:2
- -
Given the limited case data and the frequency in samples unselected for long QT (1% of Finnish individuals) we consider this a variant likely benign. Di Resta et al (2015) identified this variant in one individual with Brugada syndrome. No individual phenotypic information was available, but the cohort consisted of 91 unrelated patients with Brugada syndrome on the basis of either type I ECG, spontaneous or induced by flecainide or ajmaline infusion and who were SCN5A-negative. It is a non-conservative amino acid substitution of a hydrophobic Tyrosine with a hydrophilic Histidine at a conserved residue. In silico analysis with PolyPhen2 predicts the variant is probably damaging. No other variants have been reported in this region of AKAP9. However, ExAC constraint analyses of AKAP9 appears to be tolerant to missense variation (Z= -2.75), as well as loss of function/truncating variation (pLI=0.00). The variant is listed in dbSNP (rs61757557). The ClinSeq group reported it in 1 of 854 individuals not selected for long QT syndrome (Ng et al 2013). The variant was reported online in a total of 217 of 138,602 individuals in the Genome Aggregation Consortium Dataset (gnomAD; http://gnomad.broadinstitute.org/), which currently includes variant calls on >140,000 unrelated individuals of African, Asian, European, Latino, and Ashkenazi descent. It was seen in 129 of 13,003 Finnish individuals (0.99%), 71 of 61,939 European individuals (0.11%), and 12 of 17,980 Latino individuals (0.06%). -
Congenital long QT syndrome Uncertain:1
- -
Long QT syndrome Benign:1
- -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at